Current and Future Developments of Predictive Markers and Prognostic Testing in IBD

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Making a Difference: Patient-Centered Ulcerative Colitis Care in the Era of JAK Inhibitors and S1P Modulators
Making a Difference: Patient-Centered Ulcerative Colitis Care in the Era of JAK Inhibitors and S1P Modulators
CME/CE
Making a Difference: Patient-Centered Ulcerative Colitis Care in the Era of JAK Inhibitors and S1P Modulators
0.75 credits
- Alan C. Moss, MD, FACG, FEBG, AGAF, FRCPI
- Sophie M. Balzora, MD
- Latonia Ward, M.Min
0.75 credits
IL-12/23 and IL-23 Receptor Antagonists
IL-12/23 and IL-23 Receptor Antagonists
CME/CE
IL-12/23 and IL-23 Receptor Antagonists
0.50 credits
- Sara Horst, MD, MPH
0.50 credits
IBD Immunology and Emerging Therapies: Where Are We and Where We Are Going
IBD Immunology and Emerging Therapies: Where Are We and Where We Are Going
CME/CE
IBD Immunology and Emerging Therapies: Where Are We and Where We Are Going
0.50 credits
- Matthew Ciorba, MD
0.50 credits
2022 Crohn's & Colitis Congress
2022 Crohn's & Colitis Congress
CME/CE
2022 Crohn's & Colitis Congress